Daily Chart

Popular Trending Tickers


Ticker Sitemap
Will LLBO go up?

Send a Tweet

Lifeline Biotechnologies, Inc. - LLBO Insiders

No Insiders

We have no insiders for Lifeline Biotechnologies right now.

Know someone who is an insider on Lifeline Biotechnologies, Inc.?
Let us know.

Lifeline Biotechnologies, Inc. - LLBO/LLBO.PK information

Lifeline Biotechnologies, Inc. operates as a medical technology company in the United States. Its technologies focus on prevention, early detection, diagnosis, and quick recovery of various disease conditions. The company is developing a non-imaging technology, known as the First Warning System, which measures tissue activity for the early detection of breast cancer in women. Lifeline Biotechnologies was incorporated in 1981 and is based in Reno, Nevada....
www.lbti.com
Founded in 1981

LIFELINE BIOTECHNOLOGIES INC (LLBO:OTC US)

LAST $0.0006 USD
CHANGE TODAY 0.0001 20.00%
VOLUME 860.0K
As of 11:07 AM 07/30/10 All times are local (Market data is delayed by at least 15 minutes).

Snapshot of LIFELINE BIOTECHNOLOGIES INC (LLBO)

OPEN
$0.0006
PREVIOUS CLOSE
$0.0005
DAY HIGH
$0.0006
DAY LOW
$0.0006
52 WEEK HIGH
07/30/09 - $0.01
52 WEEK LOW
07/22/10 - $0.0004
MARKET CAP
--
AVERAGE VOLUME 10 D
2.4M
EPS TTM
--
SHARES OUTSTANDING
0.0
LLBO Does Not Pay Dividends
P/E TTM
--
K = Thousands  M = Millions  B = Billions
[addPosition2]

Key developments for LIFELINE BIOTECHNOLOGIES INC (LLBO)

Lifeline Biotechnologies, Inc. expected to report First-Half, 2010 results on September 22, 2010. This event was calculated by Capital IQ (Created on June 27, 2010).

Lifeline Biotechnologies, Inc. expected to report First-Half, 2010 results on September 22, 2010. This event was calculated by Capital IQ (Created on June 27, 2010).

Lifeline Biotechnologies, Inc. expected to report Fiscal Year 2010 results on April 1, 2011. This event was calculated by Capital IQ (Created on June 27, 2010).

Lifeline Biotechnologies, Inc. expected to report Fiscal Year 2010 results on April 1, 2011. This event was calculated by Capital IQ (Created on June 27, 2010).

Lifeline Biotechnologies Inc. Prepares an FDA Filing for First Warning System

Lifeline Biotechnologies Inc. announced that management is preparing for a filing with the FDA for the company's First Warning System(TM), a capable process designed to assist in the early detection of breast cancer. Lifeline Biotechnologies has in the past year filed for a patent on the recent technological advancements of the First Warning System(TM), which has achieved the robust capability of identifying and classifying tissue abnormalities of the breast with sensitivities (ability to identify) of 95% to 100% and specificities (verify) of 87% to 90%. Currently, it is a well known fact that mammograms are missing an estimated 20% to 30% of the breast cancers.

LLBO Competitors

Company Last Change
No competitor information is available for LLBO.
Market data is delayed at least 15 minutes.
 

Industry Analysis

Valuation LLBO Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book 0.2x
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful

LLBO

 | 

LLBO transactions

Type
Date
Target
No transactions in the last 6 months.

Lifeline Biotechnologies, Inc. - LLBO/LLBO.PK news

Lifeline Biotechnologies Retains Legal Counsel to Resolve Trading Issue with Depository Trust Services

Keywords: Lifeline Biotechnologies Retains Legal Counsel to Resolve Trading Issue with Depository Trust Services, llbo.pk
Quote:
Read article

Lifeline Biotechnologies Comments on Depository Trust Services

Keywords: Lifeline Biotechnologies Comments on Depository Trust Services, llbo.pk
Quote:
Read article

Lifeline Biotechnologies Comments on DTC Notice Resulting from SEC Administrative Action Against Leeb Brokerage Services, Inc.

Keywords: Lifeline Biotechnologies Comments on DTC Notice Resulting from SEC Administrative Action Against Leeb Brokerage Services, Inc., llbo.pk
Quote: As a consequenceof the SEC action, Depository Trust Company (DTC) has suspended allservices, except custody services, for Lifeline Biotechnologies shares.Lifeline is one of a number of companies whose shares were allegedlyutilized in the activities of the brokerage firm Leeb. According to anSEC administrative action in 2006, Leeb conducted possible illegaltrading for clients holding shares of Lifeline and other companies.Lifeline’s CEO, Jim Holmes, stated, “Lifeline has no knowledge...
Read article

Skymark Research Initiates Complimentary Research Coverage On Lifeline BioTechnologies, Inc.

Quote: Press ReleaseSource: Skymark ResearchOn Friday July 24, 2009, 9:30 am EDTCALGARY, Alberta, July 24, 2009 (GLOBE NEWSWIRE) -- Skymark Research, a leading provider of small- and micro-cap independent investment research, today initiated coverage on Lifeline BioTechnologies, Inc.(Pink Sheets: - ). Skymark Research is currently offering a complimentary trial subscription. To view our research go to:Skymark Research is a leading provider of independent investment research in North America. Our servic...
Read article

Lifeline Biotechnologies Updates Pink Sheets

Quote:
Read article

Lifeline Biotechnologies Reports on an Update to the First Warning System's Advanced Analytical Capabilities

Quote:
Read article

Lifeline Biotechnologies Reports on FDA Filing Preparation

Quote: Our software system technologywas developed by Lifeline Biotechnologies, together with our ‘PatternRecognition’ experts at Nanyang Technological University, Singapore."Once the review has been completed we intend to move forward afully-compliant 510(k) submission. The submission will be based on theregulatory strategy and could/should be filed by midyear 2010."We've also received many questions concerning the prospect of a reversesplit of the common stock. Even though the outstandin...
Read article

Lifeline Biotechnologies Reports on FDA Filing Status

Quote:
Read article

Lifeline Biotechnologies Reports on FDA Filing Preparation

Quote: Our software system technologywas developed by Lifeline Biotechnologies, together with our ‘PatternRecognition’ experts at Nanyang Technological University, Singapore."Once the review has been completed we intend to move forward afully-compliant 510(k) submission. The submission will be based on theregulatory strategy and could/should be filed by midyear 2010."We've also received many questions concerning the prospect of a reversesplit of the common stock. Even though the outstandin...
Read article

Lifeline Biotechnologies Reports on FDA Filing Status

Quote:
Read article

Lifeline Biotechnologies Updates Pink Sheets

Quote:
Read article

Skymark Research Initiates Complimentary Research Coverage On Lifeline BioTechnologies, Inc.

Quote: Press ReleaseSource: Skymark ResearchOn Friday July 24, 2009, 9:30 am EDTCALGARY, Alberta, July 24, 2009 (GLOBE NEWSWIRE) -- Skymark Research, a leading provider of small- and micro-cap independent investment research, today initiated coverage on Lifeline BioTechnologies, Inc.(Pink Sheets: - ). Skymark Research is currently offering a complimentary trial subscription. To view our research go to:Skymark Research is a leading provider of independent investment research in North America. Our servic...
Read article

Lifeline Biotechnologies Reports on an Update to the First Warning System's Advanced Analytical Capabilities

Quote:
Read article

Lifeline Biotechnologies Updates Pink Sheets

Quote:
Read article

Lifeline Biotechnologies Reports on FDA Filing Status

Quote:
Read article

Lifeline Biotechnologies Completes the Updating of Pink Sheets

Quote:
Read article
Stocktweeting is not a financial advisor, and in no way recommends the purchase of any stock or advise on the suitability of any trade or investment.
Stock trading and investing can cause loss of capital, and you should always consult with a professional financial advisor before trading or investing.